Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

such as eosinophilic esophagitis, which occurs in an estimated 10% to 15% of children undergoing upper endoscopy for GERD symptoms. [6,11] The diagnostic tests that are useful in the evaluation of ...

Cannabis use is associated with higher inflammation after EoE treatment, which may indicate a negative effect.

In cases where no other manifestation of lichen planus are found and direct immunofluorescence for fibrinogen along the basement membrane is negative, the term “lichenoid esophagitis ... Histology of ...

For example, endoscopy is used for malignancy surveillance of Barrett's esophagus and assessment of experimental treatments for eosinophilic esophagitis. It's also used to facilitate the placement of ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Eupraxia Pharmaceuticals (EPRX)announced additional positive clinical data from its RESOLVE Phase 1b/2a trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

One can even trigger a digestive disease which makes it hard to swallow. It's known as EOE - Eosinophilic Esophagitis. For more than 30 years, Mimi Martinez has put her heart and soul into ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in ...